CLEC5A-HER2 bispecific antibodyHER2-positive breast cancerHER2-targeted therapies
…out significant toxicity.Conclusions These results identify the CLEC5A-HER2 bispecific antibody as a potential immunotherapy for HER2-positive cancers by effec…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…out significant toxicity.Conclusions These results identify the CLEC5A-HER2 bispecific antibody as a potential immunotherapy for HER2-positive cancers by effec…